AKTX
Akari Therapeutics
AKTX
AKTX
5 hedge funds and large institutions have $177K invested in Akari Therapeutics in 2015 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 3 closing their positions.
Holders
5
Holders Change
-2
Holders Change %
-28.57%
% of All Funds
0.13%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
2
Reduced
1
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
UBS Group
Zurich,
Switzerland
|
$2K |
| 2 |
AIG
2
American International Group
New York
|
$348 |
Top Sellers
| 1 |
VKH
1
Virtu KCG Holdings
New York
|
$0 |
| 2 |
2
Citadel Advisors
Miami,
Florida
|
$9K |
| 3 |
3
Wells Fargo
San Francisco,
California
|
$0 |
| 4 |
4
Citigroup
New York
|
$0 |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
CAM
1
Cormorant Asset Management
Boston,
Massachusetts
| $166K | 286,508 | – | – |
|
|
2
Citadel Advisors
Miami,
Florida
| $9K | 15,249 | -13,345 | -47% |
|
|
3
UBS Group
Zurich,
Switzerland
| $2K | 3,350 | +2,014 | +151% |
|
|
AIG
4
American International Group
New York
| $348 | 600 | +600 | New |
|
|
VKH
5
Virtu KCG Holdings
New York
| – | – | -33,567 | Closed |
|
|
6
Wells Fargo
San Francisco,
California
| – | – | -1,200 | Closed |
|
|
7
Citigroup
New York
| – | – | -761 | Closed |
|
8
Morgan Stanley
New York
| $0 | 8 | +1 | +14% |
|